Home / News (Page 3)

News

Invectys, Inc appoints Biopharma Veteran, Praveen Tyle,...

Invectys, Inc appoints Biopharma Veteran, Praveen Tyle, PhD as President & CEO   Houston, TX, USA, May 4, 2021 (GLOBE NEWSWIRE) – Invectys, Inc., a clinical-stage…

Read more

AACR Annual Meeting 2021

AACR Annual Meeting 2021 April 10th – 15th 2021   Invectys was at the AACR’s Annual Meeting 2021. Although online, the AACR Annual Meeting still carried…

Read more

Invectys’ CARGo project: $14.2M 2020 CPRIT Award

Invectys well poised to bring its anti-HLA-G CAR-T cells to clinical trials …

Read more

Invectys reports in vivo efficacy of its pan anti-tumor...

Invectys reports in vivo efficacy of its pan anti-tumor anti-HLA-G CAR-T cells These results open new perspectives in oncology for targeting cancer through HLA-G,…

Read more

Invectys : Dennis J. Purcell (Aisling Capital) join Adv...

Invectys Strengthens Advisory Board with the Appointment of Dennis J. Purcell, Life Sciences Industry Veteran and Founder of Aisling Capital LLC Paris, France, May…

Read more

Invectys publishes positive clinical results for its IN...

Invectys publishes positive clinical results for its INVAC-1 Phase I Study in Clinical Cancer Research   With an extended Phase I and a new delivery method…

Read more

Tête à Tête décideurs – Pierre Langlade Demoyen, ...

Invectys : lutter contre toutes les formes de cancers Avec 382 000 nouveaux cas et 157 400 décès par an, le cancer demeure une priorité absolue en matière de…

Read more

8th International Conference on HLA-G

8th International Conference on HLA-G July 8th – 9th 2019 Ministère de la Santé et des Solidarités, Paris, France Invectys will be attending the 8th International…

Read more